FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely ribavirin 20 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ribavirin 20 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely lamotrigine 5 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely lamotrigine 5 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Morphine sulfate 75 mg rectal suppository Has presentation strength denominator value False un Inferred relationship Some 1
    Morphine sulfate 75 mg rectal suppository Count of base of active ingredient False un Inferred relationship Some
    Dosulepin 15 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Dosulepin 15 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely iloprost 10 microgram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely iloprost 10 microgram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely guanethidine 20 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely guanethidine 20 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely alendronic acid (as alendronate sodium) 933 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely alendronic acid (as alendronate sodium) 933 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely guanethidine 10 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely guanethidine 10 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cefotaxime sodium 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely cefotaxime sodium 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely guanethidine 30 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely guanethidine 30 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Mupirocin (as mupirocin calcium) 20 mg/mL cutaneous cream Count of base of active ingredient False un Inferred relationship Some
    Mupirocin (as mupirocin calcium) 20 mg/mL cutaneous cream Has concentration strength denominator value False un Inferred relationship Some 1
    Paracetamol 650 mg and pentazocine 25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Paracetamol 650 mg and pentazocine 25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely didanosine 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely didanosine 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cefotaxime sodium 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely cefotaxime sodium 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Pegaptanib (as pegaptanib sodium) 3.33 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Pegaptanib (as pegaptanib sodium) 3.33 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely apraclonidine (as apraclonidine hydrochloride) 10 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely apraclonidine (as apraclonidine hydrochloride) 10 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely sodium hyaluronate 23 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely sodium hyaluronate 23 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely cefotaxime sodium 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely cefotaxime sodium 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Fluocortolone caproate 2.5 mg/g and fluocortolone pivalate 2.5 mg/g cutaneous ointment Has concentration strength denominator value False un Inferred relationship Some 1
    Fluocortolone caproate 2.5 mg/g and fluocortolone pivalate 2.5 mg/g cutaneous ointment Count of base of active ingredient False un Inferred relationship Some
    Fluocortolone caproate 2.5 mg/g and fluocortolone pivalate 2.5 mg/g cutaneous ointment Has concentration strength denominator value False un Inferred relationship Some 2
    Aspirin 2.5 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Aspirin 2.5 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely clotrimazole 100 milligram/1 each conventional release vaginal tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely clotrimazole 100 milligram/1 each conventional release vaginal tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely sodium stibogluconate 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely sodium stibogluconate 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely teniposide 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely teniposide 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Budesonide 200 microgram/actuation solution for inhalation Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely clotrimazole 200 milligram/1 each conventional release vaginal tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely clotrimazole 200 milligram/1 each conventional release vaginal tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Cyanocobalamin 500 microgram/actuation nasal spray Count of base of active ingredient False un Inferred relationship Some
    Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely carmellose 166 milligram/1 gram conventional release oral paste (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely carmellose 166 milligram/1 gram conventional release oral paste (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely ciclosporin 500 microgram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely ciclosporin 500 microgram/1 milliliter conventional release eye suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Sterculia gum 620 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Sterculia gum 620 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely dihydroergotamine mesilate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely dihydroergotamine mesilate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely dihydroergotamine mesilate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength numerator value False un Inferred relationship Some 1
    Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Levobunolol hydrochloride 5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Levobunolol hydrochloride 5 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely budesonide 250 microgram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely budesonide 250 microgram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely dihydroergotamine mesilate 500 microgram/1 actuation conventional release nasal spray (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely benzocaine 200 milligram/1 milliliter conventional release ear solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely benzocaine 200 milligram/1 milliliter conventional release ear solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely sodium chloride 9 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely sodium chloride 9 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely aspirin 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely aspirin 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely budesonide 500 microgram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely budesonide 500 microgram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Chlorpromazine hydrochloride 2 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Chlorpromazine hydrochloride 2 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Adrenaline 1 mg/mL nasal solution Has concentration strength numerator value False un Inferred relationship Some 1
    Adrenaline 1 mg/mL nasal solution Has concentration strength denominator value False un Inferred relationship Some 1
    Adrenaline 1 mg/mL nasal solution Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely sodium chloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely sodium chloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely chlorpromazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely chlorpromazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely meptazinol 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely meptazinol 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Adrenaline (as adrenaline acid tartrate) 500 microgram/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Adrenaline (as adrenaline acid tartrate) 500 microgram/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely glucose 100 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely glucose 100 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely didanosine 1 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False un Inferred relationship Some 1

    Start Previous Page 197 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start